Corient Private Wealth’s CACI CACI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Buy
24,281
+15,621
+180% +$7.98M 0.02% 603
2026
Q1
$4.7M Sell
8,660
-24,917
-74% -$15M 0.01% 873
2025
Q4
$18M Sell
33,577
-469
-1% -$265K 0.02% 426
2025
Q3
$17M Buy
34,046
+17,706
+108% +$8.56M 0.03% 424
2025
Q2
$7.79M Buy
16,340
+6,227
+62% +$2.76M 0.01% 582
2025
Q1
$3.71M Sell
10,113
-1,212
-11% -$464K 0.01% 768
2024
Q4
$4.58M Sell
11,325
-2,797
-20% -$1.36M 0.01% 728
2024
Q3
$7.13M Sell
14,122
-473
-3% -$219K 0.01% 653
2024
Q2
$6.28M Sell
14,595
-134
-0.9% -$54.7K 0.01% 645
2024
Q1
$5.58M Buy
14,729
+422
+3% +$150K 0.01% 684
2023
Q4
$4.63M Buy
14,307
+1,274
+10% +$413K 0.01% 713
2023
Q3
$4.09M Sell
13,033
-767
-6% -$257K 0.01% 686
2023
Q2
$4.7M Sell
13,800
-3,347
-20% -$1.04M 0.01% 647
2023
Q1
$5.08M Sell
17,147
-347
-2% -$102K 0.01% 590
2022
Q4
$5.26M Buy
+17,494
New +$5.1M 0.02% 492

Other funds holding CACI

Corient Private Wealth's CACI Position: Q2 2026 in Review

Corient Private Wealth increased its CACI (CACI) stake by 180% in Q2 2026, buying an estimated $7.98M and bringing the position to 24,281 shares worth $11.2M. The position accounts for 0.02% of the portfolio, ranked #603.

Corient Private Wealth first reported a position in CACI in Q4 2022 and has held it in 15 quarters since. The position peaked at $18M in Q4 2025. 616 funds tracked by Wall St. Rank hold CACI as of Q2 2026.

  • Corient Private Wealth held 24,281 shares of CACI worth $11.2M as of Q2 2026.
  • Corient Private Wealth bought 15,621 CACI shares in Q2 2026, an estimated $7.98M.
  • CACI made up 0.02% of Corient Private Wealth's portfolio in Q2 2026, its #603 holding.
  • Corient Private Wealth first reported a position in CACI in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's CACI position peaked at $18M in Q4 2025.
  • 616 funds tracked by Wall St. Rank held CACI as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.